Deep analysis of pleural effusion proteomes for lung cancer biomarkers discovery
碩士 === 長庚大學 === 生物醫學研究所 === 101 === Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, which is the prominent cause of the death in Taiwan. Because of organ proximal and smaller dilution effects, pleural effusion (PE) would be a good source for biomarker discovery in NSCLC. H...
Main Authors: | Pei Jun Liu, 柳佩君 |
---|---|
Other Authors: | C. J. Yu |
Format: | Others |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/08003839566709320681 |
Similar Items
-
A targeted proteomics pipeline reveals potential biomarkers for diagnosis of metastatic lung cancer in pleural effusion
by: Chi De Chen, et al.
Published: (2014) -
Development of a novel protein biomarker panel for lung cancer by integration of cancer cell secretome & pleural effusion proteome
by: Yu Ming Deng, et al.
Published: (2010) -
Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion
by: Hai Zhang, et al.
Published: (2020-10-01) -
Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
by: Chen KY, et al.
Published: (2016-06-01) -
Potential Angiogenetic Biomarkers in Non-small Cell Lung Cancer with Malignant Pleural Effusion
by: I-Lin Hsu, et al.
Published: (2008)